Notification That Annual Report Will Be Submitted Late (nt 10-k)
March 31 2021 - 1:32PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check
One):
|
☒ Form
10-K
|
☐ Form
20-F
|
☐ Form
11-K
|
☐
Form 10-Q
|
☐ Form
10-D
|
☐ Form
N-SAR
|
☐ Form
N-CSR
|
For
Period Ended: December 31, 2020
☐
|
Transition
Report on Form 10-K
|
☐
|
Transition
Report on Form 20-F
|
☐
|
Transition
Report on Form 11-K
|
☐
|
Transition
Report on Form 10-Q
|
☐
|
Transition
Report on Form N-SAR
|
For the
Transition Period Ended: December 31, 2020
Nothing in this form shall be construed to imply that the
Commission has verified any information contained
herein.
If the
notification relates to a portion of the filing checked above,
identify the items(s) to which the notification
relates:
PART I
REGISTRANT INFORMATION
GENETHERA, INC.
Full
Name of Registrant:
N/A
Former
Name if Applicable
3051 W
105th
Ave. Unit
350251
Address
of Principal Executive Office (Street and Number)
Westminster, CO 80035
City,
State and Zip Code
PART II
RULES 12b-25(b) AND (c)
If the
subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed. (Check box if
appropriate)
☒
|
(a)
|
The
reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or
expense;
|
☒
|
(b)
|
The
subject annual report, semi-annual report, transition report on
Form 10-K, Form 20- F, 11-K, 10-Q, Form N-SAR, or portion thereof,
will be filed on or before the fifteenth calendar day following the
prescribed due date; or the subject quarterly of transition report
on Form 10-Q, or portion thereof be filed on or before the fifth
calendar day following prescribed due date; and
|
|
|
|
___
|
(c)
|
The
accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
|
|
|
|
PART III
NARRATIVE
State
below in reasonable detail the reasons why the Form 10-K, 11-K,
20-F, 10-Q, N-SAR, or the transition report or portion thereof,
could not be filed within the prescribed time period.
The
Company is unable to file its Annual Report on Form 10-K for the
period ended December 31, 2020 within the prescribed period due to
delay in providing the accounting data for review and audit by our
auditor. Such delay prevents the Company from filing the Annual
Report without unreasonable effort or expense. The Company fully
expects to be able to file within the additional time allowed by
this report.
PART IV
OTHER INFORMATION
(1)
|
Name
and telephone number of person to contact in regard to this
notification.
|
|
Tannya L. Irizarry
|
(720)
|
587-5100
|
|
|
(Name)
|
(Area
Code)
|
(Telephone
Number)
|
|
(2)
|
Have
all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such
shorter period that the registrant was required to file such
report(s) been filed? If answer is no, identify
report(s).
|
☒ Yes ☐ No
(3)
|
Is it
anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject
report or portion thereof?
|
☐ Yes ☒ No
GENETHERA, INC.
(Name
of Registrant as Specified in Charter)
has
caused this notification to be signed on its behalf by the
undersigned hereunto duly authorized.
Date:
March 31, 2021
|
By: /s/
TANNYA L. IRIZARRY
|
|
Tannya
L. Irizarry
|
|
CFO
|
GeneThera (CE) (USOTC:GTHR)
Historical Stock Chart
From Dec 2024 to Jan 2025
GeneThera (CE) (USOTC:GTHR)
Historical Stock Chart
From Jan 2024 to Jan 2025